M. Griffith

775 total citations
10 papers, 517 citations indexed

About

M. Griffith is a scholar working on Genetics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. Griffith has authored 10 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. Griffith's work include Pancreatic and Hepatic Oncology Research (4 papers), Glioma Diagnosis and Treatment (4 papers) and Neuroendocrine Tumor Research Advances (2 papers). M. Griffith is often cited by papers focused on Pancreatic and Hepatic Oncology Research (4 papers), Glioma Diagnosis and Treatment (4 papers) and Neuroendocrine Tumor Research Advances (2 papers). M. Griffith collaborates with scholars based in United States. M. Griffith's co-authors include Daniel T. Chang, Daniel A. Laheru, Albert C. Koong, Joseph M. Herman, Jonathan Pai, Amy Hacker‐Prietz, Christopher L. Wolfgang, Siva P. Raman, Avani Satish Dholakia and Timothy M. Pawlik and has published in prestigious journals such as Cancer, Biochemical and Biophysical Research Communications and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

M. Griffith

9 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Griffith United States 7 346 212 136 115 96 10 517
V. Grégoire France 12 133 0.4× 265 1.3× 104 0.8× 38 0.3× 32 0.3× 35 454
Hann‐Hsiang Chao United States 13 85 0.2× 139 0.7× 46 0.3× 54 0.5× 58 0.6× 31 547
R. Bonnet Germany 15 289 0.8× 500 2.4× 14 0.1× 86 0.7× 97 1.0× 28 813
Sebastian Lange Germany 12 179 0.5× 85 0.4× 62 0.5× 76 0.7× 14 0.1× 25 384
Bin Qiu China 14 124 0.4× 113 0.5× 27 0.2× 104 0.9× 50 0.5× 40 398
George Shenouda Canada 15 72 0.2× 275 1.3× 29 0.2× 83 0.7× 224 2.3× 40 555
M. Garofalo Italy 10 101 0.3× 144 0.7× 67 0.5× 23 0.2× 54 0.6× 36 446
S Becker United States 11 56 0.2× 235 1.1× 168 1.2× 141 1.2× 312 3.3× 51 628
I. Strøyer Denmark 10 111 0.3× 336 1.6× 33 0.2× 33 0.3× 180 1.9× 17 695
P. V. Hansen Denmark 7 159 0.5× 100 0.5× 28 0.2× 49 0.4× 64 0.7× 8 357

Countries citing papers authored by M. Griffith

Since Specialization
Citations

This map shows the geographic impact of M. Griffith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Griffith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Griffith more than expected).

Fields of papers citing papers by M. Griffith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Griffith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Griffith. The network helps show where M. Griffith may publish in the future.

Co-authorship network of co-authors of M. Griffith

This figure shows the co-authorship network connecting the top 25 collaborators of M. Griffith. A scholar is included among the top collaborators of M. Griffith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Griffith. M. Griffith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Rao, Avani D., Elizabeth A. Sugar, Daniel T. Chang, et al.. (2016). Patient-reported outcomes of a multicenter phase 2 study investigating gemcitabine and stereotactic body radiation therapy in locally advanced pancreatic cancer. Practical Radiation Oncology. 6(6). 417–424. 16 indexed citations
2.
Herman, Joseph M., Daniel T. Chang, Karyn A. Goodman, et al.. (2014). Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma. Cancer. 121(7). 1128–1137. 342 indexed citations
3.
Dholakia, Avani Satish, Muhammad Chaudhry, Jeffrey P. Leal, et al.. (2014). Baseline Metabolic Tumor Volume and Total Lesion Glycolysis Are Associated With Survival Outcomes in Patients With Locally Advanced Pancreatic Cancer Receiving Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 89(3). 539–546. 63 indexed citations
4.
Dholakia, Avani Satish, Daniel T. Chang, Karyn A. Goodman, et al.. (2013). A Phase 2 Multicenter Study to Evaluate Gemcitabine and Fractionated Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Adenocarcinoma. International Journal of Radiation Oncology*Biology*Physics. 87(2). S28–S28. 5 indexed citations
5.
Moon, James E., Robert G. Rivard, M. Griffith, et al.. (2006). Effect of timing and duration of azithromycin therapy of leptospirosis in a hamster model. Journal of Antimicrobial Chemotherapy. 59(1). 148–151. 9 indexed citations
7.
Karanfil, Lynne V., et al.. (1999). Reducing the rate of nosocomially transmitted respiratory syncytial virus. American Journal of Infection Control. 27(2). 91–96. 43 indexed citations
8.
Griffith, M., et al.. (1995). Detection of loss of cerebral vascular tone by correlation of arterial and intracranial pressure signals. IEEE Transactions on Biomedical Engineering. 42(4). 420–424. 29 indexed citations
9.
Griffith, M.. (1966). The World-Wide Malaria Eradication Program. Bulletin of the Entomological Society of America. 12(2). 130–136. 4 indexed citations
10.
Najjar, Victor A. & M. Griffith. (1964). The heterogeneity of the antibody site to a given antigenic determinant. Biochemical and Biophysical Research Communications. 16(5). 472–477. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026